Shopping Cart 0
Cart Subtotal
USD 0

ARCA biopharma Inc (ABIO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment and prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. It provides medical treatment to the individual genetic characteristics of each patient and personalized medicine approach to drug development. ARCA also develops AB171, a thiol-substituted isosorbide mononitrate for genetically targeted treatment of peripheral arterial disease and heart failure. The company works in partnership with universities to improve the health of cardiovascular patients. ARCA is headquartered in Westminster, Colorado, the US.

ARCA biopharma Inc (ABIO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ARCA biopharma Inc, Medical Equipment, Deal Details 10

Partnerships 10

Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10

Equity Offering 11

ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11

Arca Biopharma Raises USD37 Million in Private Placement of Units 12

ARCA biopharma Inc-Key Competitors 14

ARCA biopharma Inc-Key Employees 15

ARCA biopharma Inc-Locations And Subsidiaries 16

Head Office 16

Recent Developments 17

Financial Announcements 17

May 08, 2018: ARCA Biopharma announces first quarter 2018 financial results and provides corporate update 17

Mar 22, 2018: ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update 18

Nov 09, 2017: ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update 19

Aug 03, 2017: ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update 20

May 15, 2017: ARCA Biopharma Announces First Quarter 2017 Financial Results 22

Mar 21, 2017: ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update 23

Corporate Communications 25

Feb 21, 2017: Anders Hove, MD Joins ARCA biopharma Board of Directors 25

Other Significant Developments 26

Feb 02, 2018: ARCA Biopharma Selects TransPerfect's Trial Interactive eTMF Solution 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

ARCA biopharma Inc, Medical Equipment, Key Facts, 2017 2

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Deals By Market, 2012 to YTD 2018 8

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10

ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11

Arca Biopharma Raises USD37 Million in Private Placement of Units 12

ARCA biopharma Inc, Key Competitors 14

ARCA biopharma Inc, Key Employees 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

ARCA biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment and prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. It provides medical treatment to the individual genetic characteristics of each patient and personalized medicine approach to drug development. ARCA also develops AB171, a thiol-substituted isosorbide mononitrate for genetically targeted treatment of peripheral arterial disease and heart failure. The company works in partnership with universities to improve the health of cardiovascular patients. ARCA is headquartered in Westminster, Colorado, the US.

ARCA biopharma Inc (ABIO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

ARCA biopharma Inc, Medical Equipment, Deal Details 10

Partnerships 10

Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10

Equity Offering 11

ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11

Arca Biopharma Raises USD37 Million in Private Placement of Units 12

ARCA biopharma Inc-Key Competitors 14

ARCA biopharma Inc-Key Employees 15

ARCA biopharma Inc-Locations And Subsidiaries 16

Head Office 16

Recent Developments 17

Financial Announcements 17

May 08, 2018: ARCA Biopharma announces first quarter 2018 financial results and provides corporate update 17

Mar 22, 2018: ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update 18

Nov 09, 2017: ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update 19

Aug 03, 2017: ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update 20

May 15, 2017: ARCA Biopharma Announces First Quarter 2017 Financial Results 22

Mar 21, 2017: ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update 23

Corporate Communications 25

Feb 21, 2017: Anders Hove, MD Joins ARCA biopharma Board of Directors 25

Other Significant Developments 26

Feb 02, 2018: ARCA Biopharma Selects TransPerfect's Trial Interactive eTMF Solution 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

ARCA biopharma Inc, Medical Equipment, Key Facts, 2017 2

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

ARCA biopharma Inc, Deals By Market, 2012 to YTD 2018 8

ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10

ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11

Arca Biopharma Raises USD37 Million in Private Placement of Units 12

ARCA biopharma Inc, Key Competitors 14

ARCA biopharma Inc, Key Employees 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

ARCA biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat